Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Photocontact allergy and photopatch testing
Sally H Ibbotson
Photocontact allergy is uncommon and considered to be a delayed type IV hypersensitivity reaction, in which a photoactivated chemical acts as an antigen or hapten. Photopatch testing is used to investigate and diagnose photocontact allergy; sunscreen chemicals are the major group of clinically relevant photoallergens. Both sunscreen users with normal sun sensitivity and patients with existing photosensitive diseases may develop photocontact allergy, and this needs to be considered as a differential diagnosis in the presentation of a patient with a photoexposed site dermatitis or with a history of a reaction to a sunscreen.
Dermatology in practice
2002;
10
(3): 16–19
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Melanoma patients in England to access skin cancer vaccine through NHS programme
Amino acid sequence could significantly reduce psoriasis symptoms
J&J announces positive phase 3b results for Tremfya in psoriatic arthritis
Organon’s Vtama cream shows sustained benefit in atopic dermatitis patients
Almirall hosts Skin Academy to advance skin science
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy